000488114 000__ 01713cam\a2200349\a\4500
000488114 001__ 488114
000488114 005__ 20210513171548.0
000488114 006__ m\\\\\o\\d\\\\\\\\
000488114 007__ cr\cn|||||||||
000488114 008__ 090630s2009\\\\nyu\\\\\ob\\\\001\0\eng\d
000488114 010__ $$z  2009027054
000488114 020__ $$z9781606928431 (hardcover)
000488114 020__ $$z9781613243725 (e-book)
000488114 035__ $$a(CaPaEBR)ebr10671002
000488114 035__ $$a(OCoLC)705945748
000488114 040__ $$aCaPaEBR$$cCaPaEBR
000488114 043__ $$an-us---
000488114 05014 $$aRS55.2$$b.G465 2009eb
000488114 08204 $$a338.4/76151$$222
000488114 24500 $$aGeneric drugs$$h[electronic resource] :$$bneeds and issues /$$cRyan S. Blanton, editor.
000488114 260__ $$aNew York :$$bNova Science Publishers,$$c2009.
000488114 300__ $$a157 p.
000488114 4901_ $$aHealth care issues, costs and access
000488114 504__ $$aIncludes bibliographical references and index.
000488114 5050_ $$aAuthorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, January 17, 2007 / U.S. Government Printing Office -- Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, March 26, 2007 / U.S. Government Printing Office.
000488114 506__ $$aAccess limited to authorized users.
000488114 650_0 $$aGeneric drugs$$zUnited States.
000488114 7001_ $$aBlanton, Ryan S.
000488114 830_0 $$aHealth care issues, costs, and access.
000488114 852__ $$bebk
000488114 85640 $$3ProQuest Ebook Central Academic Complete$$uhttps://univsouthin.idm.oclc.org/login?url=http://site.ebrary.com/lib/usiricelib/Doc?id=10671002$$zOnline Access
000488114 909CO $$ooai:library.usi.edu:488114$$pGLOBAL_SET
000488114 980__ $$aEBOOK
000488114 980__ $$aBIB
000488114 982__ $$aEbook
000488114 983__ $$aOnline